This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, Y.
Right arrow Articles by Nahm, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Y.
Right arrow Articles by Nahm, M. H.

 Previous Article  |  Next Article 

Infection and Immunity, January 2001, p. 336-344, Vol. 69, No. 1
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.1.336-344.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Avidity, Potency, and Cross-Reactivity of Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide Serotype 6B

Yan Sun, Young-il Hwang,dagger and Moon H. Nahm*

Departments of Pediatrics and Pathology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

Received 26 June 2000/Returned for modification 5 September 2000/Accepted 5 October 2000

Many pneumococcal capsular polysaccharides (PSs) are similar in structure, and a pneumococcal antibody often binds to all of the PSs with a similar structure. Yet, these cross-reactive antibodies may bind to the structurally related pneumococcal capsular PSs with an avidity too low to be effective. If memory B cells producing such weakly cross-reactive antibodies are elicited with pneumococcal conjugate vaccines, the memory cells for low-avidity antibodies could compromise the subsequent immune responses to the cross-reactive PS (original antigenic sin). To investigate these issues, we produced 14 hybridomas secreting monoclonal antibodies (MAbs) to the capsular PS of Streptococcus pneumoniae serotype 6B by immunizing BALB/c mice with antigens containing 6B PS and studied their epitope, avidity, in vitro opsonizing capacity, in vivo protective capacity, and "antigen binding titer" by enzyme-linked immunosorbent assay (ELISA) of 6A and 6B capsular PSs. Six MAbs bound to the non-cross-reactive 6B-specific epitope, and seven MAbs bound to the cross-reactive epitope present in both 6A and 6B PSs One MAb (Hyp6BM6) revealed a novel epitope. This epitope was found on 6A PS in solution, but not on 6A PS adsorbed onto the plastic surface of the ELISA plates. The avidity of the MAb for 6A or 6B PS ranged from 7.8 × 106 M-1 to 4.1 × 1011 M-1. No MAbs were weakly cross-reactive, since none of the cross-reactive MAbs showed any tendency toward having less avidity to 6A PS (the cross-reactive PS) than to 6B PS. Avidity influenced the results of several antibody assays. When all of the hybridomas were examined, avidity strongly correlated with the titer of a unit amount of MAb to bind antigen-coated ELISA plates (r = 0.91) or to opsonize pneumococci in vitro (r = -0.85). Because both assay results are avidity dependent, the ELISA and the opsonization assay results were strongly correlated (r = 0.91), regardless of avidity. Avidity also correlated with the potency of a MAb to passively protect mice against pneumococcal infections. When only the immunoglobulin G hybridomas were examined, little increase in opsonizing capacity and in vivo protective potency was observed above 109 M-1. Taken together, an ELISA measuring antigen binding titer may be an adequate measure of the protective immunity induced with pneumococcal vaccines, and the absence of a partially cross-reactive MAb suggests that antigenic sin may not be significant in responses to vaccines against the S. pneumoniae 6B serotype.

* Corresponding author. Mailing address: University of Rochester School of Medicine and Dentistry, Departments of Pediatrics and Pathology, 601 Elmwood Ave., Box 608, Rochester, NY 14642. Phone: (716) 273-4157. Fax: (716) 273-1101. E-mail: moon_nahm{at}urmc.rochester.edu.

dagger Present address: Department of Anatomy, Seoul National University, College of Medicine, Chongno-gu, Yeungeun-dong, Seoul 110-799, Korea.

Infection and Immunity, January 2001, p. 336-344, Vol. 69, No. 1
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.1.336-344.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Bratcher, P. E., Park, I. H., Hollingshead, S. K., Nahm, M. H. (2009). Production of a unique pneumococcal capsule serotype belonging to serogroup 6. Microbiology 155: 576-583 [Abstract] [Full Text]  
  • Safari, D., Dekker, H. A. T., Joosten, J. A. F., Michalik, D., de Souza, A. C., Adamo, R., Lahmann, M., Sundgren, A., Oscarson, S., Kamerling, J. P., Snippe, H. (2008). Identification of the Smallest Structure Capable of Evoking Opsonophagocytic Antibodies against Streptococcus pneumoniae Type 14. Infect. Immun. 76: 4615-4623 [Abstract] [Full Text]  
  • Park, I. H., Pritchard, D. G., Cartee, R., Brandao, A., Brandileone, M. C. C., Nahm, M. H. (2007). Discovery of a New Capsular Serotype (6C) within Serogroup 6 of Streptococcus pneumoniae. J. Clin. Microbiol. 45: 1225-1233 [Abstract] [Full Text]  
  • Pashov, A., MacLeod, S., Saha, R., Perry, M., VanCott, T. C., Kieber-Emmons, T. (2005). Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12. Glycobiology 15: 994-1001 [Abstract] [Full Text]  
  • Yu, J., Lin, J., Benjamin, W. H. Jr., Waites, K. B., Lee, C.-h., Nahm, M. H. (2005). Rapid Multiplex Assay for Serotyping Pneumococci with Monoclonal and Polyclonal Antibodies. J. Clin. Microbiol. 43: 156-162 [Abstract] [Full Text]  
  • Mavroidi, A., Godoy, D., Aanensen, D. M., Robinson, D. A., Hollingshead, S. K., Spratt, B. G. (2004). Evolutionary Genetics of the Capsular Locus of Serogroup 6 Pneumococci. J. Bacteriol. 186: 8181-8192 [Abstract] [Full Text]  
  • Burns, T., Zhong, Z., Steinitz, M., Pirofski, L.-a. (2003). Modulation of Polymorphonuclear Cell Interleukin-8 Secretion by Human Monoclonal Antibodies to Type 8 Pneumococcal Capsular Polysaccharide. Infect. Immun. 71: 6775-6783 [Abstract] [Full Text]  
  • Wernette, C. M., Frasch, C. E., Madore, D., Carlone, G., Goldblatt, D., Plikaytis, B., Benjamin, W., Quataert, S. A., Hildreth, S., Sikkema, D. J., Kayhty, H., Jonsdottir, I., Nahm, M. H. (2003). Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides. CVI 10: 514-519 [Full Text]  
  • Harris, S. L., King, W. J., Ferris, W., Granoff, D. M. (2003). Age-Related Disparity in Functional Activities of Human Group C Serum Anticapsular Antibodies Elicited by Meningococcal Polysaccharide Vaccine. Infect. Immun. 71: 275-286 [Abstract] [Full Text]  
  • Shin, J.-S., Yu, J., Lin, J., Zhong, L., Bren, K. L., Nahm2, M. H. (2002). Peptide Mimotopes of Pneumococcal Capsular Polysaccharide of 6B Serotype: A Peptide Mimotope Can Bind to Two Unrelated Antibodies. J. Immunol. 168: 6273-6278 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»